Last reviewed · How we verify

Vorapaxar and Aspirin

Inova Health Care Services · FDA-approved active Small molecule Quality 5/100

Vorapaxar and Aspirin is a Small molecule drug developed by Inova Health Care Services. It is currently FDA-approved. Also known as: Group 3.

At a glance

Generic nameVorapaxar and Aspirin
Also known asGroup 3
SponsorInova Health Care Services
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Vorapaxar and Aspirin

What is Vorapaxar and Aspirin?

Vorapaxar and Aspirin is a Small molecule drug developed by Inova Health Care Services.

Who makes Vorapaxar and Aspirin?

Vorapaxar and Aspirin is developed and marketed by Inova Health Care Services (see full Inova Health Care Services pipeline at /company/inova-health-care-services).

Is Vorapaxar and Aspirin also known as anything else?

Vorapaxar and Aspirin is also known as Group 3.

What development phase is Vorapaxar and Aspirin in?

Vorapaxar and Aspirin is FDA-approved (marketed).

Related